Jun 06, 2025
Cloud computing in the healthcare industry is growing at an immense pace. Despite some difficulties, the advantages of cloud computing are more compared to disadvantages
Read More...
May 27, 2025
In the last two decades, many advancement yielded new insights, paving way for promising therapeutic approaches for dermatomyositis treatment.
Read More...
Mar 24, 2025
Weight loss/Weight management (Obesity) Market is dominated by various treatment approaches including medications, medical devices, apps, and
Read More...
Mar 14, 2025
80+ pharma companies are working to assess challenges & seek opportunities that could influence obesity treatment scenario in coming years.
Read More...
Mar 02, 2025
On September 29, 2023, FDA approved EXXUA, the ER gepirone hydrochloride tablets by Fabre-Kramer, for major depressive disorder treatment.
Read More...
Mar 02, 2025
The major depressive disorder treatment market is expected to surge owing to the launch of novel therapies and key companies in the market.
Read More...
Feb 15, 2025
In today's highly dynamic and fast-changing market, Competitive Intelligence plays a crucial role in making strategically smart decisions to outsmart the competition
Read More...
Feb 12, 2025
Donanemab is a promising new Alzheimer’s disease treatment. Donanemab has the potential to rule the Alzheimer’s disease market.
Read More...
Feb 12, 2025
Despite facing significant setbacks, companies such as Eli Lilly, BioVie, and others are developing effective Alzheimer's disease treatments.
Read More...
Feb 06, 2025
Polycythemia vera treatment market is expected to substantially change and it will be dominated by approved products, JAKAFI and BESREMi.
Read More...
A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray
Jun 10, 2025
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
Newsletter/Whitepaper